Headline News about Springworks Therapeutics Inc
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://investorplace.com/wp-content/uploads/2022/10/droplet-test-tube-biotech-1600-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
SpringWorks Therapeutics: Q4 Earnings Insights
February 27, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/12/05/apple-1853337.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Analyst Ratings for SpringWorks Therapeutics
November 29, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for SpringWorks Therapeutics
August 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for SpringWorks Therapeutics
July 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/30/image36.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/30/la-z-boy_-_logo.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
The Latest Analyst Ratings for SpringWorks Therapeutics
June 06, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
SpringWorks Therapeutics: Q1 Earnings Insights
May 03, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Analyst Expectations for SpringWorks Therapeutics's Future
April 20, 2023
Via Benzinga
4 Analysts Have This to Say About SpringWorks Therapeutics
December 01, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/11/28/image20.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 28, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2020/07/Stock-cancerblood-02-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/28/pdd_holdings_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_6947.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/28/image34.jpeg?width=1200&height=800&fit=crop)
Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
November 28, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/11/28/swtx.png?width=1200&height=800&fit=crop)
FDA Approves SpringWorks Therapeutics' Lead Therapy As First For Subtype Of Soft Tissue Sarcomas
November 28, 2023
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/11/16/aapharma_7.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/24/swtx.png?width=1200&height=800&fit=crop)
SpringWorks' Investigational Cancer Treatment Is Standard Care, Analyst Unfazed By FDA Update
August 24, 2023
Via Benzinga
Exposures
Product Safety
![](https://investorplace.com/wp-content/uploads/2022/10/stocks-to-buy-greedy1600-1024x576.png)
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022
December 01, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/23/screenshot_2022-11-23_at_7.14.20_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_2117.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.